Clinical Trials on Cell- and Tissue-Based Therapy in United Kingdom

Total 38522 results

Solent NHS Trust
University of Oxford; Talking Change (Solent NHS Trust); Constable & Robinson

Completed

RCT of Bibliotherapy for Social Anxiety Disorder as a Prelude to CBT in IAPT (RCT of CBB/CBT)

Social Anxiety Disorder | Cognitive Behavioral Therapy | Bibliotherapy

United Kingdom
University College, London
AstraZeneca; Cancer Research UK

Withdrawn

Phase I Trial of Vandetanib Combined With 131I-mIBG to Treat Patients With Advanced Phaeochromocytoma and Paraganglioma (VIBRaNT)

Paraganglioma | Phaeochromocytoma

United Kingdom
Royal Marsden NHS Foundation Trust
University of Leeds; University of Manchester

Terminated

Trial of Pembrolizumab and Radiotherapy in Melanoma (PERM)

Melanoma

United Kingdom
King's College Hospital NHS Trust

Recruiting

The Incidence and Outcomes of Metabolically Active Brown Adipose Tissue (aBAT) in Patients With Pheochromocytoma or Paraganglioma (PPGLs)

Pheochromocytoma | Paraganglioma

United Kingdom
GlaxoSmithKline

Active, not recruiting

Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

Neoplasms

United States, Netherlands, Canada, United Kingdom
Immodulon Therapeutics Ltd
Theradex; HCA International Limited

Completed

A Clinical Study, to Evaluate the Safety and Tolerability of Intradermal IMM-101 in Adult Melanoma Cancer Patients

Melanoma

United Kingdom
3M

Terminated

Evaluation of V.A.C. VERAFLO CLEANSE CHOICE™ Dressing Using Normal Saline to Promote Increased Healthy Wound Bed Tissue

Wounds and Injuries | Wound Heal | Wound | Granulation Tissue | Negative-pressure Wound Therapy

United States
European Organisation for Research and Treatment...

Terminated

Chemotherapy in Treating Patients With Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor

Sarcoma

United Kingdom
Royal Marsden NHS Foundation Trust

Completed

Pain Prevalence and Risk Factors Among Sarcoma/Melanoma Oncology Patients in an Outpatients Setting

Melanoma | Sarcoma

United Kingdom
The Christie NHS Foundation Trust
Bristol-Myers Squibb; University of Manchester; Manchester Academic Health Science...

Active, not recruiting

CAcTUS - Circulating Tumour DNA Guided Switch (CAcTUS)

Melanoma

United Kingdom
Vitaccess Ltd
Royal Marsden NHS Foundation Trust; Melanoma UK

Completed

The Impact of Melanoma and Drug Treatment in the Real World

Melanoma

United Kingdom
Moletest Scotland Ltd
NHS Lanarkshire; Digital Health & Care Institute

Completed

Moletest Clinical Study in Scotland

Melanoma

United Kingdom
Imperial College London

Completed

Measuring Fatty Acid Oxidation in Gliomas Using 18F-FPIA PET/MRI

Glioma

United Kingdom
Ipsen

Completed

Circulating Tumour Cells in Somatuline Autogel Treated NeuroEndocrine Tumours Patients (CALM-NET)

NeuroEndocrine Tumours

United Kingdom
Massachusetts General Hospital
M.D. Anderson Cancer Center; National Cancer Institute (NCI)

Active, not recruiting

High Dose Intensity Modulated Proton Radiation Treatment +/- Surgical Resection of Sarcomas of the Spine, Sacrum and Base of Skull

Chordoma of Sacrum | Chordoma of Spine | Chordoma of Base of Skull | Chondrosarcoma of the Spine | Chondrosarcoma of the Sacrum

United States
Arthroscopy Association of North America

Completed

Proficiency Based Training in Surgery - Employing An Arthroscopic Bankart Repair

Study Focus: Simulation and Proficiency Based Training

United States
NHS Grampian
University of Aberdeen

Recruiting

FCI in Post-operative Low Grade Gliomas

Glioma

United Kingdom
King's College Hospital NHS Trust

Recruiting

Post-operative Imaging in High Grade Glioma: is Management Influenced? (PIGMI)

Glioma

United Kingdom
Imperial College London
Biocompatibles UK Ltd, a BT International group company

Recruiting

TheraSphere Selective Internal Radiation Therapy (SIRT) as Treatment for Neuroendocrine Tumours With Liver Mets (ArTisaN)

Neuroendocrine Tumors | Liver Metastases

United Kingdom
Immodulon Therapeutics Ltd

Terminated

A Long Term Follow up Study for Patients Who Previously Took Part in the Phase I Study IMM-101-001

Malignant Melanoma

United Kingdom
King's College Hospital NHS Trust
British Renal Society; Kidney Care UK

Completed

Cultural Influences on Physical Activity and Exercise Beliefs in Patients With Chronic Kidney Disease (CULTURE-CKD)

Chronic Kidney Diseases | Physical Activity | Exercise Therapy

United Kingdom
Bournemouth University
Dorset HealthCare University NHS Foundation Trust

Completed

The Effect of Vegetable Oil on Cognitive Functions of MCI Patients (DICe)

Metabolic Ketosis | Cognitive Impairments, Mild

United Kingdom
King's College Hospital NHS Trust
King's College London

Not yet recruiting

Establishing Radiolabelled PSMA as a Target for Glioma Treatment

Glioma, Malignant

United Kingdom
Cambridge University Hospitals NHS Foundation Trust
University of Oxford; National Institute for Health Research, United Kingdom; Oxford University Hospitals NHS Trust

Completed

Continuous vs Intermittent Dabrafenib Plus Trametinib in BRAFV600 Mutant Stage 3 Unresectable or Metastatic Melanoma (INTERIM)

Melanoma

United Kingdom
University of Oxford

Unknown

Docetaxel With or Without AZD6244 in Melanoma (DOC-MEK)

Melanoma

United Kingdom
NovalGen Ltd.

Recruiting

First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies

Follicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | Non-small Cell Lung Cancer (NSCLC) | Small Lymphocytic Lymphoma | Malignant Melanoma | Chronic Lymphocytic Leukaemia

United Kingdom
Immodulon Therapeutics Ltd

Completed

A Study of IMM-101 in Combination With Checkpoint Inhibitor Therapy in Advanced Melanoma

Melanoma

United Kingdom
East of England Ambulance Service NHS Trust

Completed

Use of Blood Ketone Meters to Improve Ambulance Hyperglycaemia Care (KARMA2)

Diabetic Ketoacidosis

United Kingdom
Imperial College London

Withdrawn

CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation

Allogeneic Stem Cell Transplant | Haematological Malignancies | CD56+CD3- NK Cells

United Kingdom
King's College Hospital NHS Trust
Ampersand Health Ltd; Neuroendocrine Cancer UK

Recruiting

Mobile Application to Collect PRO Data in NET Patients

Neuroendocrine Neoplasms (Tumours)

United Kingdom
Bristol-Myers Squibb

Completed

Study of First-line Treatment Patterns and Clinical Outcomes in Patients With Advanced Melanoma in the United Kingdom

Melanoma

United Kingdom
Royal Marsden NHS Foundation Trust

Not yet recruiting

LATe TreatmENT Related Toxicity in Melanoma (LATENT) (LATENT)

Melanoma

United Kingdom
CCTU- Cancer Theme
Pierre Fabre Medicament

Not yet recruiting

Perioperative Encobini in BRAFV600 Mutant Stage III (B/C/D) or Oligometastatic Stage IV Melanoma (PREMIUM)

Melanoma | Cancer

United Kingdom
Orlucent, Inc
University Hospitals, Leicester; NHS Tayside; University of Dundee; NHS Greater... and other collaborators

Completed

Investigating the Clinical Utility of the MDS (OMS002_UK)

Melanoma | Skin Lesion | Moles

United Kingdom
Duke University

Recruiting

Hyperbaric Oxygen Therapy for Soft Tissue Sarcoma Pilot Study

Sarcoma | Hyperbaric Oxygen Therapy

United States
University of Edinburgh
NHS Lothian

Completed

Servo Controlled Oxygen Targeting Study (SCO2T)

Hypoxia | Obstetric Labor, Premature | Hyperoxia | Premature Infant | Oxygen Therapy

United Kingdom
Imperial College London
Advanced Accelerator Applications International SA

Recruiting

Lutathera and ASTX727 in Neuroendocrine Tumours (LANTana)

Neuroendocrine Tumors

United Kingdom
University College, London
University of Oxford; Cancer Research UK

Active, not recruiting

[18F] FDOPA PET Imaging in Glioma: Feasibility Study for PET Guided Brain Biopsy (FIG)

Glioma

United Kingdom
University of Surrey

Completed

Holistic Needs Assessments in Patients With Melanoma

Melanoma | Unsatisfied Needs

United Kingdom
Royal Marsden NHS Foundation Trust

Unknown

The Identification of Novel Prognostic Markers in Melanoma

Malignant Melanoma

United Kingdom
Astellas Pharma Inc

Completed

Phase 2 Study of Maintenance OSI-906 Plus Erlotinib (Tarceva®), or Placebo Plus Erlotinib in Patients With Nonprogression Following 4 Cycles of Platinum-based Chemotherapy

Non-Small Cell Lung Cancer (NSCLC) With Nonprogression Following 4 Cycles of Platinum-based Chemotherapy

United Kingdom, United States, Brazil, Canada, Germany, Korea, Republic of, Poland, Romania, Russian Federation
National Cancer Institute (NCI)

Active, not recruiting

Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers

Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Metastatic Gastroesophageal Junction Adenocarcinoma | Unresectable Gastroesophageal Junction Adenocarcinoma | Metastatic Malignant Neoplasm in the Brain and other conditions

United States
Royal Free Hospital NHS Foundation Trust
Merck Sharp & Dohme LLC; University College, London

Completed

Immunophenotyping of Melanoma Patients on Treatment With Pembrolizumab (PASIP)

Melanoma | Neoplasms

United Kingdom
Ipsen

Completed

Non Interventional Post Marketing Programme in Neuroendocrine Tumours

Neuroendocrine Tumors

United Kingdom
CMR Surgical Ltd
Liverpool University Hospitals NHS Foundation Trust; Sintesi Research S.r.l.

Recruiting

Prospective Clinical Study to Assess the Safety and Efficacy of Versius, in Transoral Robotic Surgery

Squamous Cell Carcinoma of the Oropharynx | Squamous Cell Carcinoma, Unknown Primary

United Kingdom
King's College Hospital NHS Trust

Completed

CLL Empirical Antibiotic Regimen (CLEAR)

Chronic Lymphocytic Leukaemia (CLL)

United Kingdom
University of Aberdeen
Cancer Research UK

Completed

Achieving Self-directed Integrated Cancer Aftercare (ASICA) in Melanoma (ASICA)

Melanoma

United Kingdom
University of Plymouth

Completed

Oral Nitrite Synthesis and Post-exercise Hypotension

Blood Pressure | Sports Physical Therapy

United Kingdom
University College, London

Recruiting

CAR T Cells to Target GD2 for DMG (CARMIGO)

Diffuse Midline Glioma, H3 K27M-Mutant

United Kingdom
University College, London

Recruiting

Immunotherapy for High Risk/Relapsed CD19+ Acute Lymphoblastic Leukaemia, B-cell Non-Hodgkin's Lymphoma (B-NHL) and Chronic Lymphocytic Leukaemia (CLL)/ Small Lymphocytic Lymphoma (SLL) Using CAR T-cells to Target CD19 (ALLCAR19)

Leukemia, Lymphoblastic, Acute, Lymphoma

United Kingdom

Clinical Trials on Cell- and Tissue-Based Therapy in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations